Deepinder Goyal Defends Temple Wearable Amid Scientific Criticism and Calls for Validation
Deepinder Goyal, founder of the wearable startup Temple, has defended the Rs 85,000 brain-monitoring device amid criticism from doctors questioning its scientific validity. Goyal emphasized the company's investment of around $30 million, including $20 million of his own funds, and highlighted a 14-day no-questions-asked return policy as proof of confidence. He clarified that Temple is a fitness and wellness tracker, not a medical device, and said scientific validation through pre-prints and independent studies is forthcoming. Meanwhile, medical experts remain skeptical, calling for more clinical evidence to support the device's claims about cerebral blood flow and brain health metrics.
First-hand measurement across 15 sources
We measured how 15 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 37/100.
Outlets measured: news18, indiatoday, timesnow, economictimes, ndtv, moneycontrol, mint, thehindu, and 7 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment ranged widely across outlets — from 28/100 to 62/100 — a sign the coverage itself was contested, not just reported.
Coverage timeline
inc42media broke this story on 5 Nov, 04:48 pm. Other outlets followed.